Career records & work history
Lawyers & Attorneys

Anna May Wong - Lawyer
Address:
Herbert Smith Freehills LLP
495-3636500 (Office)
495-3636500 (Office)
Licenses:
New York - Currently registered 2011
Education:
New York University School of Law

Anna Wong - Lawyer
Specialties:
Immigration, Securities & Investment Fraud, Corporate & Incorporation
ISLN:
922467158
Admitted:
2004
Medicine Doctors
Anna Wong
Specialties:
Neurology
Work:
Swedish Medical GroupSwedish Neuroscience Institute Specialists Epilepsy Center
550 17 Ave STE 540, Seattle, WA 98122
206-3203492 (phone) 206-3203088 (fax)
Site
Swedish Hospital Neurology Science Institute
550 17 Ave STE 400, Seattle, WA 98122
206-3203494 (phone) 206-3862845 (fax)
550 17 Ave STE 540, Seattle, WA 98122
206-3203492 (phone) 206-3203088 (fax)
Site
Swedish Hospital Neurology Science Institute
550 17 Ave STE 400, Seattle, WA 98122
206-3203494 (phone) 206-3862845 (fax)
Education:
Medical School
Mem Univ of Newfoundland, Fac of Med, St Johns, Nfld, Canada
Graduated: 1994
Mem Univ of Newfoundland, Fac of Med, St Johns, Nfld, Canada
Graduated: 1994
Languages:
English
Description:
Dr. Wong graduated from the Mem Univ of Newfoundland, Fac of Med, St Johns, Nfld, Canada in 1994. She works in Seattle, WA and 1 other location and specializes in Neurology. Dr. Wong is affiliated with Swedish Medical Center - First Hill.
Anna Wong
Specialties:
Family Medicine
Work:
New York Methodist Associates Of Bensonhurst
7400 18 Ave, Brooklyn, NY 11204
718-2369446 (phone) 718-2363854 (fax)
Site
7400 18 Ave, Brooklyn, NY 11204
718-2369446 (phone) 718-2363854 (fax)
Site
Languages:
Arabic, Chinese, English, Italian, Spanish
Description:
Ms. Wong works in Brooklyn, NY and specializes in Family Medicine. Ms. Wong is affiliated with New York Methodist Hospital.
License Records
Anna Wong
Licenses:
License #: 1233 - Expired
Category: Individual Optometrist
Issued Date: Aug 20, 2002
Expiration Date: Mar 8, 2003
Type: Pharmaceutical Agent (orals)
Category: Individual Optometrist
Issued Date: Aug 20, 2002
Expiration Date: Mar 8, 2003
Type: Pharmaceutical Agent (orals)